Rh incompatibility with delayed hemolytic transfusion reaction digital illustration

Rh incompatibility with delayed hemolytic transfusion reaction Save


ICD-10 code: T80.411

Chapter: Injury, poisoning and certain other consequences of external causes

Rh Incompatibility and Delayed Hemolytic Transfusion Reaction

Rh incompatibility is a condition that occurs when a person's blood type is Rh-negative and they receive a blood transfusion from an Rh-positive donor. This can lead to a delayed hemolytic transfusion reaction (DHTR), which is a rare but serious complication of blood transfusions.

During a blood transfusion, the body's immune system can recognize the new blood as foreign and attack it. This can cause the destruction of red blood cells and lead to anemia, jaundice, and other complications.

With Rh incompatibility, the body can develop antibodies against the Rh factor, a protein found on the surface of red blood cells. These antibodies can remain in the body for weeks or months, leading to a delayed reaction when the person receives another blood transfusion.

Symptoms of DHTR can include fever, chills, and a drop in blood pressure. In severe cases, it can lead to kidney failure, shock, or even death. It is important to monitor patients carefully after a blood transfusion and watch for any signs of a reaction.

  1. If a patient has a history of Rh incompatibility or a previous DHTR, doctors may recommend special blood products that have been treated to remove the Rh factor.
  2. It is also important to carefully match blood types between donors and recipients to minimize the risk of a reaction.
  3. In some cases, medications may be given to suppress the immune system and prevent the development of antibodies against the Rh factor.

In conclusion, Rh incompatibility can lead to a delayed hemolytic transfusion reaction, which can be a serious complication of blood transfusions. It is important to monitor patients carefully and take steps to minimize the risk of a reaction, including careful blood type matching and the use of special blood products when necessary.